Navigation Links
GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas
Date:7/23/2014

vation and conversion facility; also in Clark County, NV.  The Company is awaiting final State approval, expected later this year, for both the dispensary and the cultivation facility.  If both licenses are granted, and allowing some time for construction, GrowBLOX expects to be generating revenues from the cultivation and sale of legal medical cannabis in the second half of 2015.

Mr. Ellins commented, "We anticipate getting a response on our application for two additional dispensaries in the first quarter of 2015, although the timing of a response is outside of our control.  We are very excited about the prospect of adding to our Nevada presence.  This is part of our strategy of securing the rights to dispensaries and grow-sites nationwide. As we've previously announced, we have similar expansion efforts in Florida, Illinois, New York and elsewhere.  We look forward to updating our shareholders as we continue to execute on our business plan." 

About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation.  The GrowBLOXTM chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product.  The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.  http://www.gbsciences.com

Forward-Looking Statements
Except for historical information contained herein, the statements in this
'/>"/>

SOURCE GrowBLOX Sciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cardio3 BioSciences, a European biopharmaceutical company, now covered by Edison Investment Research
2. VG Life Sciences, Inc. Update on Phase I Cancer Study
3. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
4. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
5. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
6. Regado Biosciences, Inc. to Provide Third Quarter 2013 Financial Results
7. Jeeven BioSciences, Inc. Announces the Release of Its Neuro-XTM Serum-Free and Xeno-Free Tissue Culture Media
8. MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting
9. VG Life Sciences, Inc. Closes on $2,235,000 from Private Fund
10. Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo
11. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Research and Markets ( ... PharmaBiotech,s new report "Biochips and Microarrays - ... This report is an analysis of ... report starts with a description of technologies as ... array comparative genomic hybridization (CGH), copy number variation ...
(Date:9/2/2015)... Sep. 02, 2015 Research ... of Jain PharmaBiotech,s new report "Gene Therapy - ... The markets for gene therapy are difficult to ... product and it is marketed in China ... for the years 2014-2024. The estimates are based on ...
(Date:9/2/2015)... ... September 02, 2015 , ... Drug companies increasingly are ... BCC Research reveals in its new report that the U.S. will generate the ... and generates the most market demand. , BCC Research examines plant-derived drugs ...
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, ... developing treatments for urological and related conditions, announced today ... planned private placement convertible note financing, raising a total ... tranches totaling $3.175 million. Josh ... from this private placement are intended to be used ...
Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3
... CORD:USE Cord Blood Bank, a public cord blood banking facility, ... month their plans to open a family cord blood bank to ... privately bank their baby,s cord blood.  The Team of experts in ... , Joanne Kurtzberg , John Wagner , Eliane ...
... ... Complete Set of Intuitive Gene-Building Tools , ... (PRWEB) June 17, 2010 -- DNA2.0 , the leading gene synthesis and ... sequences: Gene Designer 2.0 . Building on the success of the original Gene Designer, ...
... ... (hECM) produced under proprietary conditions of hypoxia and suspension have demonstrated its ability to diminish ... and in vivo. , ... SAN DIEGO, CA (PRWEB) June 17, 2010 - Histogen, Inc., a regenerative medicine company developing ...
Cached Biology Technology:Leading Cord Blood Experts Clarify Their Support of CORD:USE Family Cord Blood Bank 2DNA2.0 Introduces Powerful, Free Gene Design Software 2DNA2.0 Introduces Powerful, Free Gene Design Software 3DNA2.0 Introduces Powerful, Free Gene Design Software 4Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation 2Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation 3
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... promising new anticancer agents could have unforeseen risks in ... School of Medicine in St. Louis. The anticancer drugs ... antagonists interfere with a biochemical process that promotes ... that interfering with this biochemical process in mice with ...
... CAMBRIDGE, Mass., June 23, 2008 Biologists at Harvard ... weapons: When threatened, these species puncture their own skin ... as claws capable of wounding predators. The unusual ... James Hanken, and Farish A. Jenkins, Jr., in a ...
... to set the agenda for urgent research in the field ... on 26 October 2008, at the European Heart House, headquarters ... Fibrillation (AF) affects several million people in the European Union. ... that one in four 40 year olds will develop AF ...
Cached Biology News:Certain anticancer agents could be harmful to patients with heart disease 2Certain anticancer agents could be harmful to patients with heart disease 3When threatened, a few African frogs can morph toes into claws 2EHRA-AFNET summit on AF 2
... a combination of an orbital shaker and ... while providing gentle, thorough mixing without foaming. ... used for a variety of applications including ... immunoblots, staining/destaining, chromatography, etc. The VSN-5 Nutating ...
... for the rapid purification of linear 100 bp ... DNA band is excised from an,agarose gel and ... base of the column are a series of ... back while allowing DNA to selectively pass through ...
...
... The Synaptic Vesicles Isolation Kit provides ... an enriched synaptic vesicle fraction. The ... lysis of the synaptosomes, and differential ... gradient. The kit also contains an ...
Biology Products: